PDCD1 and cancer: However, similar to the low response rate observed for PD-1 blockade in patients with cancer, only one study confirmed that anti-PD-1 therapy appears to be useful in PLWH with cancer (45), necessitating efforts that are aimed at improving efficacy using combined regimens.